SIGN UP LOGIN    
stemon
Country Korea, South
Tel +82-31-622-7720
URL stemon.co.kr/ko/

EXHIBITION    CI KOREA 2023

Booth No. 3G116
last updated on ( 2023-06-15 )

STEMON Inc. is a specialized cell reprogramming company that developed Entr® (ultrasound-directed permeation of Environmental transition-guided cellular reprogramming), an original technology for cell reprogramming with only ultrasound and environmental factors used without genes used, unlike conventional methods. STEMON Inc. recently developed UltraRepro®, the world's first equipment for automating Entr® core technology, and suggested alternatives to overcome a lot of problems such as the low efficiency, stability, and immune rejection of conventional cell therapies. In addition, STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the Entr® automation system, and is currently promoting the development of treatments for various intractable diseases, including immune and respiratory diseases. Accordingly, this company will develop into an innovative company that develops cell therapy products in the future.

more

EXHIBIT

COMPANY INTRODUCTION

STEMON Inc. is a specialized cell reprogramming company that developed Entr® (ultrasound-directed permeation of Environmental transition-guided cellular reprogramming), an original technology for cell reprogramming with only ultrasound and environmental factors used without genes used, unlike conventional methods. STEMON Inc. recently developed UltraRepro®, the world's first equipment for automating Entr® core technology, and suggested alternatives to overcome a lot of problems such as the low efficiency, stability, and immune rejection of conventional cell therapies. In addition, STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the Entr® automation system, and is currently promoting the development of treatments for various intractable diseases, including immune and respiratory diseases. Accordingly, this company will develop into an innovative company that develops cell therapy products in the future.

QUICK LINK

Inquiry

Sender
/
Purpose *
Available Amount for a deal *
Details

SHARE

SHARE

REQUEST THE VIDEO MEETING

  • (KST, UTC+09:00)

    This above time is Korean local time.
    The time for meeting is based on Korean local time.
    Please check Korean time, and choose the time available.
Sender
/ JNPENG(FLTECNICS)
Receiver
노시진 / stemon
Purpose *
Available Amount for a deal *
Date *
Time *
Attendee 1 *
Attendee 2
Massage